Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.95
-0.06 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
9.96
+0.01 (0.10%)
After-hours: Apr 28, 2026, 4:11 PM EDT
Bioventus Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bioventus stock have an average target of 14, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 40.70% from the current stock price of 9.95.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2026.
Analyst Ratings
The average analyst rating for Bioventus stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 2 | 1 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +40.70% | Mar 6, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +60.80% | Mar 6, 2026 |
| Barrington Research | Barrington Research | Buy Initiates $13 | Buy | Initiates | $13 | +30.65% | Feb 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +20.60% | Jul 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +50.75% | Mar 17, 2025 |
Financial Forecast
Revenue This Year
610.79M
from 568.09M
Increased by 7.52%
Revenue Next Year
653.91M
from 610.79M
Increased by 7.06%
EPS This Year
0.76
from 0.33
Increased by 130.31%
EPS Next Year
0.88
from 0.76
Increased by 16.28%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 636.5M | 690.0M | |||
| Avg | 610.8M | 653.9M | |||
| Low | 590.3M | 628.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.0% | 13.0% | |||
| Avg | 7.5% | 7.1% | |||
| Low | 3.9% | 2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.81 | 0.96 | |||
| Avg | 0.76 | 0.88 | |||
| Low | 0.73 | 0.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 145.0% | 25.7% | |||
| Avg | 130.3% | 16.3% | |||
| Low | 119.8% | 8.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.